AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
DISCRIMINATIVE STIMULUS PROPERTIES OF MCPP - EVIDENCE FOR A 5-HT2C RECEPTOR MODE OF ACTION
Authors: GOMMANS J HIJZEN TH MAES RAA OLIVIER B
Citation: J. Gommans et al., DISCRIMINATIVE STIMULUS PROPERTIES OF MCPP - EVIDENCE FOR A 5-HT2C RECEPTOR MODE OF ACTION, Psychopharmacology, 137(3), 1998, pp. 292-302
DIFFERENCES IN PLASMA-CONCENTRATIONS OF THE D-THREO AND L-THREO METHYLPHENIDATE ENANTIOMERS IN RESPONDING AND NON-RESPONDING CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
Authors: JONKMAN LM VERBATEN MN DEBOER D MAES RAA BUITELAAR JK KEMNER C VANENGELAND H KOELEGA HS
Citation: Lm. Jonkman et al., DIFFERENCES IN PLASMA-CONCENTRATIONS OF THE D-THREO AND L-THREO METHYLPHENIDATE ENANTIOMERS IN RESPONDING AND NON-RESPONDING CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER, Psychiatry research, 78(1-2), 1998, pp. 115-118
FLESINOXAN PRETREATMENT DIFFERENTIALLY AFFECTS CORTICOSTERONE, PROLACTIN AND BEHAVIORAL-RESPONSES TO A FLESINOXAN CHALLENGE
Authors: GROENINK L VANDERGUGTEN J COMPAAN JC MAES RAA OLIVIER B
Citation: L. Groenink et al., FLESINOXAN PRETREATMENT DIFFERENTIALLY AFFECTS CORTICOSTERONE, PROLACTIN AND BEHAVIORAL-RESPONSES TO A FLESINOXAN CHALLENGE, Psychopharmacology, 131(1), 1997, pp. 93-100
GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC ASSAY FOR PROFILING THE ENANTIOMERS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND ITS CHIRAL METABOLITES USING POSITIVE CHEMICAL-IONIZATION ION-TRAP MASS-SPECTROMETRY
Authors: DEBOER D TAN LP GORTER P VANDEWAL RMA KETTENESVANDENBOSCH JJ DEBRUIJN EA MAES RAA
Citation: D. Deboer et al., GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC ASSAY FOR PROFILING THE ENANTIOMERS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND ITS CHIRAL METABOLITES USING POSITIVE CHEMICAL-IONIZATION ION-TRAP MASS-SPECTROMETRY, Journal of mass spectrometry., 32(11), 1997, pp. 1236-1246
BIOANALYSIS OF RADIOIODINE LABELED METAIODOBENZYLGUANIDINE, ITS METABOLITES AND FREE RADIOIODIDE IN BODY-FLUIDS
Authors: WAFELMAN AR HOEFNAGEL CA MAES RAA BEIJNEN JH
Citation: Ar. Wafelman et al., BIOANALYSIS OF RADIOIODINE LABELED METAIODOBENZYLGUANIDINE, ITS METABOLITES AND FREE RADIOIODIDE IN BODY-FLUIDS, European journal of pharmaceutical sciences, 5(2), 1997, pp. 97-108
ACTIVATED OXAZAPHOSPHORINES ARE TRANSPORTED PREDOMINANTLY BY ERYTHROCYTES
Authors: HIGHLEY MS SCHRIJVERS D VANOOSTEROM AT HARPER PG MOMERENCY G VANCAUWENBERGHE K MAES RAA DEBRUIJN EA EDELSTEIN MB
Citation: Ms. Highley et al., ACTIVATED OXAZAPHOSPHORINES ARE TRANSPORTED PREDOMINANTLY BY ERYTHROCYTES, Annals of oncology, 8(11), 1997, pp. 1139-1144
EFFECTS OF PHENTERMINE AND PENTOBARBITAL ON CHOICE PROCESSES DURING MULTIPLE PROBABILITY-LEARNING (MPL) AND DECISION-PROCESSES MANIPULATED BY PAY-OFF CONDITIONS
Authors: VOLKERTS ER VANLAAR MW VERBATEN MN MULDER G MAES RAA
Citation: Er. Volkerts et al., EFFECTS OF PHENTERMINE AND PENTOBARBITAL ON CHOICE PROCESSES DURING MULTIPLE PROBABILITY-LEARNING (MPL) AND DECISION-PROCESSES MANIPULATED BY PAY-OFF CONDITIONS, Human psychopharmacology, 12(4), 1997, pp. 379-392
RENAL EXCRETION OF I-131-LABELED METAIODOBENZYLGUANIDINE AND METABOLITES AFTER THERAPEUTIC DOSES IN PATIENTS SUFFERING FROM DIFFERENT NEURAL CREST-DERIVED TUMORS
Authors: WAFELMAN AR HOEFNAGEL CA MAESSEN HJM MAES RAA BEIJNEN JH
Citation: Ar. Wafelman et al., RENAL EXCRETION OF I-131-LABELED METAIODOBENZYLGUANIDINE AND METABOLITES AFTER THERAPEUTIC DOSES IN PATIENTS SUFFERING FROM DIFFERENT NEURAL CREST-DERIVED TUMORS, European journal of nuclear medicine, 24(5), 1997, pp. 544-552
ENZYMATIC DEGRADATION OF METHACRYLATED DEXTRANS
Authors: FRANSSEN O VANOOIJEN RD DEBOER D MAES RAA HERRON JN HENNINK WE
Citation: O. Franssen et al., ENZYMATIC DEGRADATION OF METHACRYLATED DEXTRANS, Macromolecules, 30(24), 1997, pp. 7408-7413
EFFECTS OF 5-HT1A RECEPTOR LIGANDS IN A MODIFIED GELLER-SEIFTER CONFLICT MODEL IN THE RAT
Authors: KING CMF GOMMANS J JOORDENS RJE HIJZEN TH MAES RAA OLIVIER B
Citation: Cmf. King et al., EFFECTS OF 5-HT1A RECEPTOR LIGANDS IN A MODIFIED GELLER-SEIFTER CONFLICT MODEL IN THE RAT, European journal of pharmacology, 325(2-3), 1997, pp. 121-128
PRETREATMENT WITH 5-HT1A RECEPTOR AGONIST FLESINOXAN ATTENUATES FOS PROTEIN IN RAT HYPOTHALAMUS
Authors: COMPAAN JC GROENINK L VANDERGUGTEN J MAES RAA OLIVIER B
Citation: Jc. Compaan et al., PRETREATMENT WITH 5-HT1A RECEPTOR AGONIST FLESINOXAN ATTENUATES FOS PROTEIN IN RAT HYPOTHALAMUS, European journal of pharmacology, 324(2-3), 1997, pp. 161-168
RADIOCHEMICAL PURITY, AT EXPIRY, AND RADIOCHEMICAL STABILITY OF I-131-LABELED METAIODOBENZYLGUANIDINE CONCENTRATES FOR INTRAVENOUS-INFUSION
Authors: WAFELMAN AR HOEFNAGEL CA MAES RAA BEIJNEN JH
Citation: Ar. Wafelman et al., RADIOCHEMICAL PURITY, AT EXPIRY, AND RADIOCHEMICAL STABILITY OF I-131-LABELED METAIODOBENZYLGUANIDINE CONCENTRATES FOR INTRAVENOUS-INFUSION, Nuklearmedizin, 35(4), 1996, pp. 122-125
5-HT1A RECEPTOR AGONIST FLESINOXAN ENHANCES FOS IMMUNOREACTIVITY IN RAT CENTRAL AMYGDALA, BED NUCLEUS OF THE STRIA TERMINALIS AND HYPOTHALAMUS
Authors: COMPAAN JC GROENINK L VANDERGUGTEN J MAES RAA OLIVIER B
Citation: Jc. Compaan et al., 5-HT1A RECEPTOR AGONIST FLESINOXAN ENHANCES FOS IMMUNOREACTIVITY IN RAT CENTRAL AMYGDALA, BED NUCLEUS OF THE STRIA TERMINALIS AND HYPOTHALAMUS, European journal of neuroscience, 8(11), 1996, pp. 2340-2347
SALIVA AS A SPECIMEN FOR THERAPEUTIC DRUG-MONITORING IN PHARMACIES
Authors: ZUIDEMA J HOLD KM DEBOER D MAES RAA
Citation: J. Zuidema et al., SALIVA AS A SPECIMEN FOR THERAPEUTIC DRUG-MONITORING IN PHARMACIES, Pharmacy world & science, 18(6), 1996, pp. 193-194
INFORMATION SELECTION AND SIGNAL PROBABILITY IN MULTISOURCE MONITORING UNDER THE INFLUENCE OF CENTRALLY ACTIVE-DRUGS - PHENTERMINE VERSUS PENTOBARBITAL
Authors: VOLKERTS ER VANLAAR MW VERBATEN MN MULDER G MAES RAA
Citation: Er. Volkerts et al., INFORMATION SELECTION AND SIGNAL PROBABILITY IN MULTISOURCE MONITORING UNDER THE INFLUENCE OF CENTRALLY ACTIVE-DRUGS - PHENTERMINE VERSUS PENTOBARBITAL, Human psychopharmacology, 11(5), 1996, pp. 405-414
PHARMACOKINETICS AND PHARMACODYNAMICS OF TOPOTECAN GIVEN ON A DAILY-TIMES-5-SCHEDULE IN PHASE-II CLINICAL-TRIALS USING A LIMITED-SAMPLING PROCEDURE
Authors: VANWARMERDAM LJC CREEMERS GJ RODENHUIS S ROSING H DEBOERDENNERT M SCHELLENS JHM HUININK WWT DAVIES BE MAES RAA VERWEIJ J BEIJNEN JH
Citation: Ljc. Vanwarmerdam et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF TOPOTECAN GIVEN ON A DAILY-TIMES-5-SCHEDULE IN PHASE-II CLINICAL-TRIALS USING A LIMITED-SAMPLING PROCEDURE, Cancer chemotherapy and pharmacology, 38(3), 1996, pp. 254-260
EVALUATION OF FORMULAS USING THE SERUM CREATININE LEVEL TO CALCULATE THE OPTIMAL DOSAGE OF CARBOPLATIN
Authors: VANWARMERDAM LJC RODENHUIS S TENBOKKELHUININK WW MAES RAA BEIJNEN JH
Citation: Ljc. Vanwarmerdam et al., EVALUATION OF FORMULAS USING THE SERUM CREATININE LEVEL TO CALCULATE THE OPTIMAL DOSAGE OF CARBOPLATIN, Cancer chemotherapy and pharmacology, 37(3), 1996, pp. 266-270
ENANTIOSELECTIVE QUANTITATION OF (R)-ALPRENOLOL AND (S)-ALPRENOLOL BYGAS-CHROMATOGRAPHY MASS-SPECTROMETRY IN HUMAN SALIVA AND PLASMA
Authors: HOLD KM DEBOER D BOS KL VANOOIJEN RD ZUIDEMA J MAES RAA
Citation: Km. Hold et al., ENANTIOSELECTIVE QUANTITATION OF (R)-ALPRENOLOL AND (S)-ALPRENOLOL BYGAS-CHROMATOGRAPHY MASS-SPECTROMETRY IN HUMAN SALIVA AND PLASMA, Journal of chromatographic science, 34(1), 1996, pp. 13-19
PHARMACOKINETICS AND PHARMACODYNAMICS OF CARBOPLATIN ADMINISTERED IN A HIGH-DOSE COMBINATION REGIMEN WITH THIOTEPA, CYCLOPHOSPHAMIDE AND PERIPHERAL STEM-CELL SUPPORT
Authors: VANWARMERDAM LJC RODENHUIS S VANDERWALL E MAES RAA BEIJNEN JH
Citation: Ljc. Vanwarmerdam et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF CARBOPLATIN ADMINISTERED IN A HIGH-DOSE COMBINATION REGIMEN WITH THIOTEPA, CYCLOPHOSPHAMIDE AND PERIPHERAL STEM-CELL SUPPORT, British Journal of Cancer, 73(8), 1996, pp. 979-984
EVALUATION OF THE SALIVETTE AS SAMPLING DEVICE FOR MONITORING BETA-ADRENOCEPTOR BLOCKING-DRUGS IN SALIVA
Authors: HOLD KM DEBOER D ZUIDEMA J MAES RAA
Citation: Km. Hold et al., EVALUATION OF THE SALIVETTE AS SAMPLING DEVICE FOR MONITORING BETA-ADRENOCEPTOR BLOCKING-DRUGS IN SALIVA, Journal of chromatography B. Biomedical applications, 663(1), 1995, pp. 103-110
PROFILING 19-NORSTEROIDS .1. TANDEM MASS-SPECTROMETRIC CHARACTERIZATION OF THE HEPTAFLUOROBUTYRYL ESTER AND PENTAFLUOROBENZYLOXIME HEPTAFLUOROBUTYRYL ESTER DERIVATIVES OF 19-NORTESTOSTERONE USING COLLISIONALLYACTIVATED DISSOCIATION
Authors: DEBOER D BENSINK SN BORGGREVE AR VANOOIJEN RD MAES RAA
Citation: D. Deboer et al., PROFILING 19-NORSTEROIDS .1. TANDEM MASS-SPECTROMETRIC CHARACTERIZATION OF THE HEPTAFLUOROBUTYRYL ESTER AND PENTAFLUOROBENZYLOXIME HEPTAFLUOROBUTYRYL ESTER DERIVATIVES OF 19-NORTESTOSTERONE USING COLLISIONALLYACTIVATED DISSOCIATION, Journal of mass spectrometry., 30(3), 1995, pp. 497-504
PROFILING 19-NORSTEROIDS .2. TANDEM MASS-SPECTROMETRIC CHARACTERIZATION OF THE HEPTAFLUOROBUTYRYL ESTER AND PENTAFLUOROBENZYLOXIME HEPTAFLUOROBUTYRYL ESTER DERIVATIVES OF 19-NORANDROSTERONE USING COLLISIONLY ACTIVATED DISSOCIATION
Authors: DEBOER D BENSINK SN BORGGREVE AR VANOOIJEN RD MAES RAA
Citation: D. Deboer et al., PROFILING 19-NORSTEROIDS .2. TANDEM MASS-SPECTROMETRIC CHARACTERIZATION OF THE HEPTAFLUOROBUTYRYL ESTER AND PENTAFLUOROBENZYLOXIME HEPTAFLUOROBUTYRYL ESTER DERIVATIVES OF 19-NORANDROSTERONE USING COLLISIONLY ACTIVATED DISSOCIATION, Journal of mass spectrometry., 30(3), 1995, pp. 505-510
DOSE INDIVIDUALIZATION IN CANCER-CHEMOTHERAPY - PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIPS
Authors: VANWARMERDAM LJC VANDENBEMT BJF HUININK WWT MAES RAA BEIJNEN JH
Citation: Ljc. Vanwarmerdam et al., DOSE INDIVIDUALIZATION IN CANCER-CHEMOTHERAPY - PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIPS, Cancer research, therapy & control, 4(4), 1995, pp. 277-291
VALIDATED METHOD FOR THE DETERMINATION OF CARBOPLATIN IN BIOLOGICAL-FLUIDS BY ZEEMAN ATOMIC-ABSORPTION SPECTROMETRY
Authors: VANWARMERDAM LJC VANTELLINGEN O MAES RAA BEIJNEN JH
Citation: Ljc. Vanwarmerdam et al., VALIDATED METHOD FOR THE DETERMINATION OF CARBOPLATIN IN BIOLOGICAL-FLUIDS BY ZEEMAN ATOMIC-ABSORPTION SPECTROMETRY, Fresenius' journal of analytical chemistry, 351(8), 1995, pp. 777-781
PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF TOPOTECAN ADMINISTERED BY A 24-HOUR CONTINUOUS-INFUSION
Authors: VANWARMERDAM LJC HUININK WWB RODENHUIS S KOIER I DAVIES BE ROSING H MAES RAA BEIJNEN JH
Citation: Ljc. Vanwarmerdam et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF TOPOTECAN ADMINISTERED BY A 24-HOUR CONTINUOUS-INFUSION, Journal of clinical oncology, 13(7), 1995, pp. 1768-1776
Risultati: 1-25 | 26-44